Chlorhexidine gluconate is an antimicrobial rinse used to reduce bacteria in the mouth to treat and prevent gum disease, and it's also used as a skin cleanser before surgery or for wound care to prevent infection.[1] Peridex is currently being investigated across 27 indications[3], with its most advanced program in Phase 3.[1]
Peridex is one of 486 small molecule programs targeting HIV infection. It is currently in Phase 3.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
1931 competitors in COVID-19
Peridex
Bnt162b2
Nexavar
Calciferol
Angiomax
Benadryl
Statin
Glucocorticoid
Nadroparin
HB-Admscs
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources
Details